Daiichi Sankyo to launch vaccine JV with GSK in Japan
TOKYO (Kyodo) -- Daiichi Sankyo Co. and the Japanese unit of Britain's GlaxoSmithKline plc said Friday they have signed an agreement to establish a vaccine development and sales joint venture in Japan.
http://mdn.mainichi.jp/mdnnews/busin...bu126000c.html
Daiichi Sankyo, GlaxoSmithKline Announce Vaccine JV
Tokyo, March 2 (Jiji Press)--Daiichi Sankyo Co. <4568> and GlaxoSmithKline K.K. said Friday they will set up a joint venture to develop and sell vaccines in Japan.
http://jen.jiji.com/jc/eng?g=ind&k=2012030200493

http://www.daiichisankyo.com/news/detail/004283.html
TOKYO (Kyodo) -- Daiichi Sankyo Co. and the Japanese unit of Britain's GlaxoSmithKline plc said Friday they have signed an agreement to establish a vaccine development and sales joint venture in Japan.
http://mdn.mainichi.jp/mdnnews/busin...bu126000c.html
Daiichi Sankyo, GlaxoSmithKline Announce Vaccine JV
Tokyo, March 2 (Jiji Press)--Daiichi Sankyo Co. <4568> and GlaxoSmithKline K.K. said Friday they will set up a joint venture to develop and sell vaccines in Japan.
http://jen.jiji.com/jc/eng?g=ind&k=2012030200493
http://www.daiichisankyo.com/news/detail/004283.html